Cargando…
Opportunities to Target T Cell Trafficking in Pediatric Inflammatory Bowel Disease
T cell subsets are considered central orchestrators of inflammation and homeostasis in the intestine and are established targets for the treatment of inflammatory bowel disease. While approaches aimed at the neutralization of T cell effector cytokines have provided significant benefits for pediatric...
Autores principales: | Giannoudaki, Eirini, Gargan, Siobhan, Hussey, Seamus, Long, Aideen, Walsh, Patrick T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8012547/ https://www.ncbi.nlm.nih.gov/pubmed/33816403 http://dx.doi.org/10.3389/fped.2021.640497 |
Ejemplares similares
-
Editorial: Pediatric Inflammatory Bowel Diseases: Looking to the Future
por: Wine, Eytan, et al.
Publicado: (2020) -
Endoscopic and Histologic Predictors of Outcomes in Pediatric Ulcerative Colitis—Caveat Emptor
por: Stallard, Lorraine, et al.
Publicado: (2021) -
Adalimumab in Pediatric Inflammatory Bowel Disease
por: Choi, So Yoon, et al.
Publicado: (2022) -
The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
por: Elmaghrawy, Khalid, et al.
Publicado: (2021) -
Pancreatic Involvement in Pediatric Inflammatory Bowel Disease
por: Martín-de-Carpi, Javier, et al.
Publicado: (2017)